Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tibolone: what does tissue specific activity mean?

S Palacios1

  • 1Institute Palacios of Woman's Health, c/ Jorge Juan 36, 28001, Madrid, Spain. instituto.palacios@retemail.es

Maturitas
|February 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Nutraceuticals in the clinical management of women with breast cancer; a narrative review].

Semergen·2026
Same author

[Recommendations for the management of menopausal vasomotor symptoms in clinical practice].

Semergen·2025
Same author

Management of menopausal hot flushes. Recommendations from the Spanish Menopause Society.

European journal of obstetrics & gynecology and reproductive biology: X·2025
Same author

Improvement in menopausal symptoms with a nutritional product containing evening primrose oil, hop extract, saffron, tryptophan, vitamins B6, D3, K2, B12, and B9.

European review for medical and pharmacological sciences·2023
Same author

Sequential treatment in vulvovaginal atrophy.

Climacteric : the journal of the International Menopause Society·2023
Same author

10-month retrospective study on compliance and tolerability of the drospirenone-only pill.

European review for medical and pharmacological sciences·2023
Same journal

Urinary and vaginal symptoms in postmenopausal women: a cross-sectional online survey of Greek women.

Maturitas·2026
Same journal

Association between TyG-FI and depressive symptom trajectories in middle-aged and older adults: interaction with cognitive function and mediation analysis of sleep quality.

Maturitas·2026
Same journal

Intrinsic capacity and the trajectory of ischemic heart disease and its complications: the mediating role of insulin resistance indices.

Maturitas·2026
Same journal

Mobility limitation trajectories and longitudinal changes in delayed recall in midlife and later life: A multicohort study.

Maturitas·2026
Same journal

Digital twins in menopause: a roadmap for integrating endocrine dynamics, multisystem physiology, and precision medicine.

Maturitas·2026
Same journal

Testosterone therapy in women: Keeping pace with the evidence.

Maturitas·2026
See all related articles

Tibolone exhibits tissue-specific estrogenic, progestational, and androgenic activities. Its unique profile effectively treats menopausal symptoms without stimulating sensitive tissues, due to complex metabolic and receptor interactions.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Reproductive Medicine

Background:

  • Tibolone, a synthetic steroid, possesses weak estrogenic, progestational, and androgenic activities.
  • Its therapeutic effects are known to be tissue-dependent.
  • Understanding these mechanisms is crucial for hormone replacement therapy.

Purpose of the Study:

  • To elucidate the mechanisms behind tibolone's tissue-specific activity.
  • To explain how tibolone effectively treats menopausal symptoms while sparing breast and endometrial tissues.
  • To correlate molecular interactions with clinical outcomes.

Main Methods:

  • Review of preclinical and clinical data on tibolone's pharmacological profile.
  • Analysis of tibolone's metabolic pathways and its interaction with steroid receptors.

Related Experiment Videos

  • Investigation of local tissue metabolism and its influence on biological activity.

    • Main Results:

    • Tibolone demonstrates variable hormonal effects based on the target tissue.
    • Clinical evidence shows efficacy in managing climacteric symptoms and preventing menopausal sequelae.
    • No adverse stimulation of breast and endometrial tissues was observed.

    Conclusions:

    • Tibolone's tissue-specific action is attributed to its unique metabolism and interaction with steroid receptors.
    • Metabolic conversion to various active compounds and local tissue metabolism play key roles.
    • The balance of these mechanisms dictates the overall clinical response in specific tissues.